4//SEC Filing
Chern Carey 4
Accession 0000899243-17-024252
CIK 0000880771other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 5:07 PM ET
Size
15.7 KB
Accession
0000899243-17-024252
Insider Transaction Report
Form 4
Chern Carey
General Counsel
Transactions
- Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2017-10-13$0.83/sh−41,356$34,325→ 0 totalExercise: $10.35Exp: 2026-11-14→ Common Stock (41,356 underlying) - Exercise/Conversion
Common Stock
2017-10-13+30,000→ 31,982 total - Tax Payment
Common Stock
2017-10-13$11.18/sh−11,274$126,043→ 20,708 total - Disposition to Issuer
Common Stock
2017-10-13$11.18/sh+20,708$231,515→ 0 total - Disposition to Issuer
Incentive Stock Option (right to buy)
2017-10-13$0.83/sh−38,644$32,075→ 0 totalExercise: $10.35Exp: 2026-11-14→ Common Stock (38,644 underlying) - Exercise/Conversion
Restricted Stock Unit
2017-10-13−30,000→ 0 total→ Common Stock (30,000 underlying)
Footnotes (6)
- [F1]Each restricted stock unit represented a contingent right to receive one share of SCLN common stock upon settlement.
- [F2]Includes 773 shares of SCLN common stock acquired under Issuer's 2016 Employee Stock Purchase Plan on May 31, 2017; 746 shares of SCLN common stock acquired under Issuer's 2016 Employee Stock Purchase Plan on August 31, 2017; and 463 shares of SCLN common stock acquired under Issuer's 2016 Employee Stock Purchase Plan on October 6, 2017.
- [F3]Granted under Issuer's 2015 Equity Incentive Plan.
- [F4]Under its terms the option became exercisable in installments with 25% vesting on October 24, 2017 and 2.0833% vesting each month thereafter until it became vested in full immediately prior to the merger of Issuer and Silver Delaware Investment Limited (the "Merger").
- [F5]The option was canceled immediately prior to the Merger in exchange for a cash payment per share from the Issuer in an amount equal to the excess of $11.18 per share over the exercise price.
- [F6]Restricted stock units became fully vested and entitled to settlement immediately prior to the Merger and terminated upon settlement in shares of SCLN common stock.
Documents
Issuer
SCICLONE PHARMACEUTICALS INC
CIK 0000880771
Entity typeother
Related Parties
1- filerCIK 0001688374
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 5:07 PM ET
- Size
- 15.7 KB